| abstract |
The invention relates to novel 2-amino-substituted pyridines which are produced by first converting corresponding pyridine aldehydes into the corresponding hydroxides by means of metal-organic compounds such as Grignard compounds, and then reducing said hydroxides to a deshydroxy compound. The novel 2-amino-substituted pyridines are suitable for use as active ingredients in medicaments, particularly those used in the treatment of arteriosclerosis. |